Tsai Chen Lung
SEC Form 4 insider trading activity
Tsai Chen Lung has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jul 1, 2026.
On the most recent filing, Tsai Chen Lung is listed as Director at CapsoVision, Inc. Inside the rolling window, Tsai Chen Lung reported 1 open-market purchase totaling $83 in CV and no open-market sales.
Companies traded
Other insiders at CV
Insider Buying
$83
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Tsai Chen Lung made?
Tsai Chen Lung has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Tsai Chen Lung trade?
Tsai Chen Lung has filed SEC Form 4 disclosures for 1 company, including CV.
When was Tsai Chen Lung's most recent SEC Form 4 filing?
Tsai Chen Lung's most recent SEC Form 4 filing on Tracefour is dated Jul 1, 2026.
What is Tsai Chen Lung's total buy and sell value in the current window?
Inside the rolling retention window, Tsai Chen Lung bought $83 and sold $0 based on SEC Form 4 filings.
What was Tsai Chen Lung's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 20 CV shares on 2025-07-03, worth $83, per SEC Form 4 filings.